Clinical and Microbiological Outcomes of Ceftazidime-Avibactam Treatment in Adults with Gram-Negative Bacteremia: A Subset Analysis from the Phase 3 Clinical Trial Program

INTRODUCTION: This exploratory analysis assessed efficacy and safety outcomes in patients with Gram-negative bacteremia treated with ceftazidime-avibactam or comparator across five phase 3, randomized, controlled, multi-center trials in adults with complicated intra-abdominal infection (cIAI), compl...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazuski, John E., Wagenlehner, Florian, Torres, Antoni, Carmeli, Yehuda, Chow, Joseph W., Wajsbrot, Dalia, Stone, Gregory G., Irani, Paurus, Bharucha, David, Cheng, Karen, Tawadrous, Margaret
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353612/
https://www.ncbi.nlm.nih.gov/pubmed/34374952
http://dx.doi.org/10.1007/s40121-021-00506-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353612/
https://www.ncbi.nlm.nih.gov/pubmed/34374952
http://dx.doi.org/10.1007/s40121-021-00506-7

Ejemplares similares